Sector: Pharmaceuticals & Biotechnology

Mid Cap

Procter & Gamble Health Share Price

PGHL

₹5,869

40.50(0.69%)

24th Aug 2026 | 11:24 AM

NSE : PGHL

Open Free Demat Account

Procter & Gamble Health Performance

Price Movement

₹5869.00

₹5830.00

₹5919.50

↘ Today's Low↗ Today's High

1 Year Performance

₹5869.00

₹4707.00

₹6975.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹5,919.50

Low₹5,830.00

Open at₹5,833.50

Prev Close₹5,828.50

Volumes4.30 K

Avg Price₹5,872.42

Lower Circuit₹4,663.00

Upper Circuit₹6,994.00

Historical Performance

3M High₹6,975.00

3M Low₹5,306.00

1 Yr High₹6,975.00

1 Yr Low₹4,707.00

3 Yr High₹6,975.00

3 Yr Low₹4,636.55

5 Yr High₹6,975.00

5 Yr Low₹3,870.10

Summary

As of 24-08-2026 12:01, Procter & Gamble Health Ltd. share price today is ₹0, with a change of ₹-5828.50 (-100.00%) from the previous close of ₹5828.5. The stock opened at ₹5833.5 and traded between ₹5830 and ₹5919.5, with a total traded volume of 4297 shares. The company has a market capitalization of ₹9681.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹6975 and ₹4707, respectively.

Procter & Gamble Health Ltd. valuation metrics include a P/E ratio of 27.1, and book value of ₹18.50. Profitability indicators show ROE of 62.32% along with a dividend yield of 3.5%. Procter & Gamble Health Ltd. has reported revenue of ₹1432.94 Cr and net profit of ₹356.88 Cr.

Procter & Gamble Health Ltd. technical indicators include Day RSI at 27.81, Day MFI at 3.75, Day ADX at 38.25. Additional indicators include Commodity Channel Index (CCI) at -101.7 and Williams %R at -96.43. Momentum indicators show Day MACD at -184.56, Day MACD Signal Line at -118.46, DayATR at 166.15. Rate of Change indicators for Procter & Gamble Health Ltd. include ROC125 at 15.87 and ROC21 at -14.73.

Exponential moving averages include EMA5 at ₹5864.6, EMA10 at ₹5985, EMA12 at ₹6030.5, EMA20 at ₹6163.5, EMA26 at ₹6215.1, EMA50 at ₹6209.2, EMA100 at ₹6012.1, EMA200 at ₹5826.5. Simple moving averages include SMA5 at ₹5862.2, SMA10 at ₹5947.2, SMA20 at ₹6276, SMA30 at ₹6454, SMA50 at ₹6383.8, SMA100 at ₹5848, SMA150 at ₹5616, SMA200 at ₹5662.4.

Support levels for Procter & Gamble Health are placed at First Support ₹5725.83, Second Support ₹5670.67, Third Support ₹5590.33. Resistance levels are seen at First Resistance ₹5861.33, Second Resistance ₹5941.67, Third Resistance ₹5996.83. Procter & Gamble Health Ltd. shareholding pattern shows promoter holding at 51.82%, FII holding at 6.33%, DII holding at 0%, public holding at 29.41%.

Procter & Gamble Health Fundamentals

Market Cap

Above industry Median

9,681.60 Cr.

PE Ratio (TTM)

Above industry Median

27.10

Dividend Yield

Market Runner Up

3.50

Net Profit TTM

18.7% incr over last year

356.88

Net Profit Growth

18.7% incr over last year

356.88

PEG Ratio

Above industry Median

1.40

ROE

42.8% incr over last year

62.32

Operating Revenue TTM

1,432.94

Operating Revenue Growth

12.6% incr over last year

Book Value

High in industry

18.50

MFI

MFI strongly Oversold

3.75

RSI

RSI oversold

27.81

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

18.50

Procter & Gamble Health Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	363.71	370.45	373.86	324.92	338.74
Operating Expense	264.11	234.86	263.40	204.65	248.40
Operating Profit	99.60	135.59	110.46	120.27	90.34
Depreciation	0.14	6.17	5.90	6.08	5.44
Interest	6.02	0.21	0.10	0.12	0.12
Tax	32.97	38.61	31.23	30.48	22.63
Net Profit	96.15	94.60	77.59	88.54	66.18

Procter & Gamble Health Technicals

Procter & Gamble Health Ltd. EMA & SMA

₹5869.00

88.00 (1.52%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹5864.6

Day EMA10 ₹5985

Day EMA12 ₹6030.5

Day EMA20 ₹6163.5

Day EMA26 ₹6215.1

Day EMA50 ₹6209.2

Day EMA100 ₹6012.1

Day EMA200 ₹5826.5

Procter & Gamble Health Support and Resistance

Resistance

First Resistance₹5861.33

Second Resistance₹5941.67

Third Resistance₹5996.83

Support

First Support₹5725.83

Second Support₹5670.67

Third Support₹5590.33

Technical Indicators

Day RSI27.81

Day MFI3.75

Day ADX38.25

Day Commodity Channel Index-101.70

William-96.43

Day MACD-184.56

Day MACD Signal Line-118.46

Day ATR166.15

Day ROC12515.87

Day ROC21-14.73

Procter & Gamble Health Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	51.8	51.8	51.8	51.8	51.8	51.8
FII	6.9	7	7.2	7	6.2	6.3
DII	14.2	14.1	13.9	13.8	13.7	12.5
Public	27.1	27	27	27.4	28.3	29.4

Procter & Gamble Health Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	6.02 K	11.5 K	52.33%
Week	8.14 K	11.9 K	68.36%
1 Month	8.43 K	17.79 K	47.39%
6 Month	12.87 K	23.64 K	54.44%

Procter & Gamble Health SWOT Analysis

Strengths21

Weakness6

Opportunity2

Threats2

Companies with no Debt

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Mid-range Performer (DVM)

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Volume Shockers

Procter & Gamble Health Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
27 Aug, 2026	45	FINAL	27 Aug, 2026	Equity Share
12 Feb, 2026	50	SPECIAL	12 Feb, 2026	Equity Share
12 Feb, 2026	110	INTERIM	12 Feb, 2026	Equity Share
22 Aug, 2025	45	FINAL	22 Aug, 2025	Equity Share
21 Feb, 2025	80	INTERIM	21 Feb, 2025	Equity Share
28 Nov, 2024	60	FINAL		Equity Share
14 Feb, 2024	50	INTERIM	14 Feb, 2024	Equity Share
14 Feb, 2024	150	SPECIAL	14 Feb, 2024	Equity Share
23 Nov, 2023	50	FINAL		Equity Share
13 Feb, 2023	45	INTERIM	13 Feb, 2023	Equity Share

Procter & Gamble Health Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Senores Pharmaceuticals Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹2,158.70	₹1,125.85	₹1,566	₹1,527	₹4,190.20	₹774.50
% Change	0.75%	1.26%	3.48%	-0.52%	-0.76%	3.27%
Revenue TTM (₹ Cr)	₹1,479.07	₹675.61	₹691.72	₹1,543.34	₹949.80	₹4,501.61
Net Profit TTM (₹ Cr)	₹199.03	₹182.64	₹126.37	₹-48.62	₹266	₹291.72
PE TTM	65.20	71.50	56.50	-358.60	36.60	40.60
1 Year Return	99.76	95.01	121.72	-17.12	-19	57.13
ROCE	31.54	24.22	15.60	0.59	-	11.40

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 1078.70

-0.90%

BLUEJET

Blue Jet Healthcare Ltd

₹ 605.00

+1.48%

CONCORDBIO

Concord Biotech Ltd.

₹ 1536.20

-2.23%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 843.00

+3.21%

SUPRIYA

Supriya Lifescience Ltd.

₹ 803.80

-0.20%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1346.60

-0.32%

COHANCE

Cohance Lifesciences Ltd.

₹ 452.20

-2.33%

ERIS

Eris Lifesciences Ltd.

₹ 1313.80

-1.08%

SYNGENE

Syngene International Ltd.

₹ 401.30

-1.46%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 815.00

-0.82%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 197.07

+0.18%

STAR

Strides Pharma Science Ltd.

₹ 981.30

-0.50%

FDC

FDC Ltd.

₹ 348.40

-0.06%

SHILPAMED

Shilpa Medicare Ltd.

₹ 862.35

+5.82%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 891.55

+1.27%

NATCOPHARM

Natco Pharma Ltd.

₹ 885.00

+0.29%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2500.00

-2.37%

MARKSANS

Marksans Pharma Ltd.

₹ 322.60

+0.40%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1020.50

+1.84%

VIYASH

Viyash Scientific Ltd.

₹ 268.60

-2.66%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 7265.00

-2.03%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 570.50

-1.49%

SANOFI

Sanofi India Ltd.

₹ 3315.00

-1.13%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 96.40

+0.41%

FAQ's on PGHL

What is the current share price of Procter & Gamble Health Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Procter & Gamble Health Ltd. is ₹ 5869 on the NSE and ₹ 5869.6 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Procter & Gamble Health Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Procter & Gamble Health Ltd. is approximately ₹ 9681.6 Cr.

What are the PE and PB ratios for Procter & Gamble Health Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Procter & Gamble Health Ltd. is 27.1, and the Price-to-Book (PB) ratio is 18.5.

What is the 52-Week High and Low for Procter & Gamble Health Ltd.?

Over the past 52 weeks, the highest price reached by Procter & Gamble Health Ltd. shares was ₹ 6975, and the lowest price was ₹ 4707.

What is the current dividend yield for Procter & Gamble Health Ltd.?

As of 6 June 2025, the dividend yield for Procter & Gamble Health Ltd. is 3.5%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Procter & Gamble Health Ltd.?

Significant shareholdings in Procter & Gamble Health Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Procter & Gamble Health Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Procter & Gamble Health Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Procter & Gamble Health Ltd.?

Procter & Gamble Health Ltd. last declared a FINAL dividend of ₹ 45 per share for the financial period ending 2026. The record date was set as 2026-08-27, and the payment was/is scheduled around 2026-08-27. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy